Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Avidity Biosciences, Inc.
| Metric | Avidity Biosciences, Inc. RNAHealthcare |
|---|---|
| Quality Score | 67 / 100 |
| Revenue (latest) | $19M |
| Net income (latest) | −$685M |
| Operating margin | −3977.3% |
| Net margin | −3650.4% |
| Return on equity | −40.5% |
| Return on assets | −35.0% |
| Return on capital (ROCE) | −42.3% |
| Debt / equity | 0.16× |
| Revenue growth (YoY) | 72.1% |
| Altman Z″ (distress) | 6.76 |
| Accruals / assets | −1.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.